NORPRAMIN (desipramine hydrochloride) by Bausch Health is mechanism of action available evidence suggests that many depressions have a biochemical basis in the form of a relative deficiency of neurotransmitters such as norepinephrine and serotonin. First approved in 1964.
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
NORPRAMIN (desipramine hydrochloride) is a secondary amine tricyclic antidepressant approved in 1964 that treats depression by blocking norepinephrine reuptake in the central nervous system. It restores normal neurotransmitter levels to address biochemical deficiencies associated with depression. The drug may show earliest therapeutic effects in 2–5 days, with full benefit typically within 2–3 weeks.
As loss of exclusivity approaches, the brand team is likely focused on niche positioning and managed care retention rather than growth expansion.
Mechanism of Action Available evidence suggests that many depressions have a biochemical basis in the form of a relative deficiency of neurotransmitters such as norepinephrine and serotonin. Norepinephrine deficiency may be associated with relatively low urinary 3-methoxy-4-hydroxyphenyl glycol…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets
To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets
Worked on NORPRAMIN at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on NORPRAMIN offers limited career advancement; the role is primarily defensive, focused on managing decline and maintaining niche market presence rather than driving growth or innovation. This assignment is best suited for professionals seeking stability in a legacy brand or those building expertise in psychiatric pharmaceuticals before transitioning to higher-growth portfolios.